APA

Thormann J., Schlepper M., Kramer W., Gottwik M. & Kindler M. (19830826). Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia. : Journal of the American College of Cardiology.

Chicago

Thormann J, Schlepper M, Kramer W, Gottwik M and Kindler M. 19830826. Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia. : Journal of the American College of Cardiology.

Harvard

Thormann J., Schlepper M., Kramer W., Gottwik M. and Kindler M. (19830826). Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia. : Journal of the American College of Cardiology.

MLA

Thormann J, Schlepper M, Kramer W, Gottwik M and Kindler M. Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia. : Journal of the American College of Cardiology. 19830826.